VEGFR2 inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VEGFR2 inhibitor, covering 2025-05-14 to 2025-05-14. Get the full timeline:
Most recent: Clinical Trial Update: BIOmarker Driven Trial of VEGFR2 Inhibitor in Advanced or Metastatic Sarcoma [Phase 2]